Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias [Phase 1]
Clinical trial update for CBX-250 in relapsed or refractory myeloid leukemias (Phase 1) that is currently recruiting at Crossbow Therapeutic…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
A clinical trial update describes a study investigating how personality traits influence adherence to tyrosine kinase inhibitor therapy in i…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib [Phase 2]
A Phase 2 trial is evaluating ponatinib hydrochloride as second-line therapy for chronic myeloid leukemia in chronic phase patients resistan…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Asciminib Roll-over Study [Phase 4]
This clinical trial update describes a Phase 4 roll-over study of asciminib for chronic myeloid leukemia that is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia [NA]
This clinical trial update describes a study evaluating how advanced practice nurses manage patients with chronic myeloid leukemia, currentl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. [Phase 2]
A Phase II clinical trial evaluating the efficacy and safety of Asciminib in patients with newly diagnosed chronic myeloid leukemia in chron…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies [Phase 2]
Phase 2 clinical trial update describing a donor stem cell transplant conditioning regimen with treosulfan, fludarabine, and total-body irra…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia [Phase 2]
The document describes a Phase 2 clinical trial evaluating a four-drug regimen (blinatumomab, methotrexate, cytarabine, and ponatinib) for P…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies [Phase 1, Phase 2]
A first-in-human study evaluating HLA partially to fully matched allogeneic, cryopreserved deceased donor bone marrow transplantation for va…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients
A planned study to evaluate the effects of tyrosine kinase inhibitors on glucose levels and lipid metabolism in chronic myeloid leukemia pat…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase [Phase 2]
Phase 2 clinical trial evaluating the combination of ASTX727 (oral decitabine/cedazuridine) with dasatinib for newly diagnosed Philadelphia …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia [Phase 2]
This clinical trial update notes a Phase II study of asciminib as second-line treatment for chronic phase chronic myeloid leukemia, and the …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France
This update covers a prospective non-interventional study of Asciminib for adult patients with chronic myeloid leukemia in chronic phase, as…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis [Phase 2]
Phase 2 clinical trial evaluating reduced-dose post-transplant cyclophosphamide as GVHD prophylaxis in HLA-mismatched unrelated donor periph…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase
An observational study update evaluating dose optimization of olverembatinib in patients with chronic myeloid leukemia in chronic or acceler…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
This clinical trial update describes ongoing strategies for CMV infection prophylaxis and management in patients with hematologic malignanci…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
MacroGenics reports a Phase 1 study of MGD024 in relapsed or refractory hematologic malignancies is currently recruiting across multiple dis…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL) [Phase 1, Phase 2]
Phase 1/2 clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of TERN-701 in adults with chronic …
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Selumetinib and Azacitidine in High Risk Chronic Blood Cancers [Phase 1]
A Phase 1 clinical trial evaluating the combination of selumetinib and azacitidine in high-risk chronic myeloid leukemia and myelofibrosis i…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment [Phase 1]
Phase 1 pharmacokinetic study evaluating how hepatic impairment affects Olverembatinib exposure, to inform dosing in patients with liver dys…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population [Phase 2]
Phase 2 clinical trial evaluating stopping tyrosine kinase inhibitors in patients with chronic myeloid leukemia who have a stable molecular …
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase [Phase 2]
This document describes a Phase II clinical trial evaluating dasatinib in combination with ropeginterferon alfa-2b for newly diagnosed chron…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
An ongoing clinical trial investigating muscle dysfunction in patients with hematologic diseases referred for stem cell transplantation.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor [Phase 2]
Phase 2 clinical trial update evaluating post-transplantation benadamustine and cyclophosphamide in high-risk myeloid malignancies with part…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase [Phase 2]
This Phase 2 clinical trial is evaluating the safety and efficacy of sequencing ponatinib followed by imatinib in patients with chronic-phas…